Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258513 · ClinicalTrials.gov registry record · NA
The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health
A NA study, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT05258513 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 83 participants.
The verdict
NCT05258513, a NA study, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study will be to examine the effectiveness of Geranylgeraniol supplementation on sexual health function in males and females following an 8-week dose escalation intervention. The study will be carried out in a randomized, double-blind, placebo-controlled, parallel manner. Participants will be stratified into quartiles based on their scores on the Derogatis Interview for Sexual Functioning during screening and prior to baseline testing. Participants from each quartile will be randomly divided by into treatment or placebo conditions. Following randomization, participants will be baseline assessed on their sexual health function using a variety of questionnaires, body composition using a whole body Dual Energy X-Ray Absorptiometry scan, blood chemistry panel, and grip strength using a hand-held dynamometer. Following baseline testing, participants will undergo 8 weeks of supplementation of their respective supplement condition. Participants will be instructed to consume two servings a day (150mg total per day) from weeks 1-4. Subject will return to the study site after 4 weeks to reassess the above-mentioned parameters. Participants will then undergo a dose escalation and be instructed to consume two servings a day (300mg total per day) from week 5-8. Sexual health questionnaires and assessments of body composition, blood chemistry, and grip strength will be conducted following the week 8 to conclude the study.
Interventions
- DIETARY_SUPPLEMENT Placebo Supplementation
- DIETARY_SUPPLEMENT GG sourced from Annatto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2022-02-06 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05258513
The ClinicalTrials.gov registry entry for NCT05258513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Supplementation is the first listed.
NCT05258513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05258513 about?
NCT05258513 is a clinical study titled "The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health". The purpose of this study will be to examine the effectiveness of Geranylgeraniol supplementation on sexual health function in males and females following an 8-week dose escalation intervention. The study will be carried out in a randomized, double-blind, placebo-controlled, parallel manner. Partici...
What is the current status of trial NCT05258513?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2022-02-06. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT05258513?
The interventions under investigation include: Placebo Supplementation (DIETARY_SUPPLEMENT), GG sourced from Annatto (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05258513?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.